Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 28 | 2018 | 3518 | 1.900 |
Why?
|
Software | 28 | 2019 | 4434 | 1.560 |
Why?
|
Sequence Analysis, Protein | 8 | 2015 | 257 | 1.180 |
Why?
|
Neoplasms | 32 | 2018 | 21596 | 1.040 |
Why?
|
Genomics | 23 | 2017 | 5692 | 0.990 |
Why?
|
Gene Expression Profiling | 37 | 2017 | 9410 | 0.850 |
Why?
|
Neoplasm Proteins | 8 | 2017 | 3691 | 0.850 |
Why?
|
MicroRNAs | 27 | 2016 | 3731 | 0.840 |
Why?
|
Systems Biology | 5 | 2015 | 469 | 0.840 |
Why?
|
Proteins | 19 | 2019 | 6096 | 0.830 |
Why?
|
Databases, Genetic | 13 | 2018 | 1780 | 0.820 |
Why?
|
Models, Chemical | 2 | 2015 | 626 | 0.820 |
Why?
|
DNA, Mitochondrial | 2 | 2017 | 814 | 0.780 |
Why?
|
Programming Languages | 5 | 2015 | 134 | 0.780 |
Why?
|
Liposarcoma | 6 | 2013 | 333 | 0.740 |
Why?
|
Signal Transduction | 33 | 2018 | 23387 | 0.730 |
Why?
|
Protein Interaction Mapping | 8 | 2015 | 627 | 0.670 |
Why?
|
DNA Copy Number Variations | 12 | 2016 | 1940 | 0.670 |
Why?
|
Models, Biological | 14 | 2015 | 9581 | 0.670 |
Why?
|
Gene Regulatory Networks | 11 | 2015 | 1707 | 0.670 |
Why?
|
Mutation | 42 | 2018 | 29717 | 0.590 |
Why?
|
Databases, Protein | 9 | 2018 | 383 | 0.570 |
Why?
|
Cell Respiration | 1 | 2017 | 200 | 0.560 |
Why?
|
Genes, Neoplasm | 5 | 2018 | 376 | 0.560 |
Why?
|
Models, Genetic | 11 | 2012 | 3493 | 0.540 |
Why?
|
DNA Mutational Analysis | 12 | 2017 | 4187 | 0.530 |
Why?
|
Entropy | 4 | 2016 | 209 | 0.530 |
Why?
|
Evolution, Molecular | 11 | 2018 | 1937 | 0.530 |
Why?
|
Gene Expression Regulation, Neoplastic | 21 | 2018 | 8425 | 0.520 |
Why?
|
Sequence Alignment | 10 | 2019 | 2257 | 0.500 |
Why?
|
Indicators and Reagents | 1 | 2014 | 462 | 0.470 |
Why?
|
Glioblastoma | 9 | 2015 | 3456 | 0.460 |
Why?
|
Cytological Techniques | 1 | 2015 | 219 | 0.460 |
Why?
|
Proteomics | 8 | 2016 | 3618 | 0.460 |
Why?
|
Carcinoma, Renal Cell | 10 | 2017 | 3123 | 0.440 |
Why?
|
RNA, Messenger | 22 | 2017 | 13029 | 0.440 |
Why?
|
Protein Array Analysis | 1 | 2014 | 411 | 0.440 |
Why?
|
Models, Molecular | 13 | 2018 | 5454 | 0.430 |
Why?
|
Protein Conformation | 10 | 2018 | 4013 | 0.420 |
Why?
|
Actigraphy | 1 | 2016 | 488 | 0.420 |
Why?
|
Databases, Factual | 12 | 2017 | 7716 | 0.420 |
Why?
|
Cell Line, Tumor | 30 | 2018 | 16665 | 0.420 |
Why?
|
Gene Dosage | 9 | 2017 | 1251 | 0.410 |
Why?
|
Internet | 17 | 2017 | 3062 | 0.410 |
Why?
|
User-Computer Interface | 9 | 2017 | 1426 | 0.400 |
Why?
|
Algorithms | 18 | 2018 | 13853 | 0.390 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 390 | 0.390 |
Why?
|
Genome, Human | 13 | 2018 | 4420 | 0.390 |
Why?
|
RNA, Small Interfering | 8 | 2012 | 3504 | 0.390 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2014 | 535 | 0.390 |
Why?
|
Computer Graphics | 5 | 2014 | 360 | 0.380 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 112 | 0.360 |
Why?
|
Metabolomics | 2 | 2018 | 1467 | 0.360 |
Why?
|
Genetic Variation | 7 | 2017 | 6540 | 0.360 |
Why?
|
Drug Resistance | 1 | 2015 | 1608 | 0.340 |
Why?
|
Drug Combinations | 2 | 2015 | 1961 | 0.340 |
Why?
|
Gene Expression Regulation | 9 | 2013 | 12071 | 0.330 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 944 | 0.330 |
Why?
|
Escherichia coli | 4 | 2018 | 4214 | 0.330 |
Why?
|
Oncogenes | 2 | 2018 | 1263 | 0.330 |
Why?
|
Information Storage and Retrieval | 7 | 2013 | 824 | 0.320 |
Why?
|
Kidney Neoplasms | 8 | 2017 | 4229 | 0.320 |
Why?
|
Mutation, Missense | 3 | 2014 | 2556 | 0.310 |
Why?
|
Protein Structure, Tertiary | 8 | 2017 | 3847 | 0.310 |
Why?
|
Systems Integration | 6 | 2010 | 440 | 0.300 |
Why?
|
Gene Silencing | 5 | 2013 | 1538 | 0.300 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2007 | 129 | 0.280 |
Why?
|
Gene Expression | 5 | 2017 | 7790 | 0.270 |
Why?
|
Proteome | 6 | 2017 | 1790 | 0.270 |
Why?
|
Models, Statistical | 5 | 2015 | 5100 | 0.270 |
Why?
|
Ovarian Neoplasms | 6 | 2013 | 4823 | 0.260 |
Why?
|
Humans | 134 | 2018 | 742088 | 0.260 |
Why?
|
Genome | 7 | 2015 | 1803 | 0.260 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 507 | 0.260 |
Why?
|
Drug Interactions | 1 | 2010 | 1458 | 0.260 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2018 | 2948 | 0.260 |
Why?
|
Escherichia coli Proteins | 3 | 2018 | 1052 | 0.260 |
Why?
|
Arousal | 3 | 2018 | 1165 | 0.250 |
Why?
|
Drug Discovery | 1 | 2013 | 1057 | 0.250 |
Why?
|
Molecular Sequence Data | 15 | 2017 | 18112 | 0.250 |
Why?
|
Antibodies | 1 | 2013 | 2459 | 0.250 |
Why?
|
Mitochondria | 2 | 2017 | 3520 | 0.250 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2006 | 314 | 0.240 |
Why?
|
Metabolism | 1 | 2006 | 193 | 0.240 |
Why?
|
Cluster Analysis | 6 | 2016 | 2713 | 0.240 |
Why?
|
Models, Theoretical | 3 | 2015 | 3584 | 0.240 |
Why?
|
DNA Polymerase II | 2 | 2015 | 107 | 0.240 |
Why?
|
Protein Biosynthesis | 3 | 2010 | 2126 | 0.230 |
Why?
|
Brain Neoplasms | 4 | 2015 | 8829 | 0.230 |
Why?
|
Sequence Analysis, RNA | 3 | 2018 | 2011 | 0.230 |
Why?
|
GTP Phosphohydrolases | 1 | 2007 | 508 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2016 | 2502 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2015 | 2940 | 0.220 |
Why?
|
Sleep | 2 | 2016 | 4604 | 0.220 |
Why?
|
Conserved Sequence | 5 | 2017 | 1202 | 0.220 |
Why?
|
PTEN Phosphohydrolase | 3 | 2014 | 1144 | 0.220 |
Why?
|
Genes, p53 | 3 | 2015 | 755 | 0.210 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 971 | 0.210 |
Why?
|
raf Kinases | 2 | 2015 | 122 | 0.210 |
Why?
|
Database Management Systems | 4 | 2012 | 270 | 0.210 |
Why?
|
Binding Sites | 9 | 2018 | 6115 | 0.210 |
Why?
|
Melanoma | 5 | 2015 | 5462 | 0.200 |
Why?
|
Computer Simulation | 7 | 2018 | 6191 | 0.200 |
Why?
|
Down-Regulation | 7 | 2015 | 3001 | 0.200 |
Why?
|
Protein Binding | 11 | 2018 | 9387 | 0.190 |
Why?
|
Transforming Growth Factor beta | 3 | 2018 | 2006 | 0.190 |
Why?
|
Genome-Wide Association Study | 7 | 2018 | 12220 | 0.190 |
Why?
|
Prostatic Neoplasms | 10 | 2018 | 11039 | 0.190 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2013 | 449 | 0.190 |
Why?
|
Gene Amplification | 4 | 2014 | 1062 | 0.190 |
Why?
|
Protein Structure, Secondary | 5 | 2016 | 1245 | 0.190 |
Why?
|
Tumor Suppressor Proteins | 6 | 2014 | 2842 | 0.180 |
Why?
|
Antineoplastic Agents | 5 | 2016 | 13655 | 0.180 |
Why?
|
ras Proteins | 5 | 2018 | 1060 | 0.180 |
Why?
|
Metabolic Networks and Pathways | 3 | 2015 | 782 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2018 | 15494 | 0.180 |
Why?
|
Amino Acid Sequence | 8 | 2017 | 13814 | 0.180 |
Why?
|
Survival Analysis | 3 | 2013 | 10248 | 0.180 |
Why?
|
Base Sequence | 12 | 2013 | 12797 | 0.170 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1758 | 0.170 |
Why?
|
Periplasmic Binding Proteins | 1 | 2018 | 33 | 0.170 |
Why?
|
DNA Methylation | 8 | 2017 | 4282 | 0.170 |
Why?
|
Genes, myc | 2 | 2011 | 399 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2018 | 2938 | 0.170 |
Why?
|
TOR Serine-Threonine Kinases | 5 | 2016 | 2107 | 0.160 |
Why?
|
Retinoblastoma Protein | 2 | 2014 | 701 | 0.160 |
Why?
|
Sequence Analysis | 1 | 2019 | 256 | 0.160 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2013 | 450 | 0.160 |
Why?
|
Microbial Consortia | 1 | 2018 | 32 | 0.160 |
Why?
|
Breast Neoplasms | 8 | 2015 | 20774 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 9 | 2018 | 17400 | 0.160 |
Why?
|
Genetic Association Studies | 4 | 2016 | 2699 | 0.150 |
Why?
|
Rest | 3 | 2018 | 900 | 0.150 |
Why?
|
Epistasis, Genetic | 2 | 2017 | 365 | 0.150 |
Why?
|
Epigenomics | 2 | 2013 | 902 | 0.150 |
Why?
|
DNA Repair | 3 | 2015 | 2042 | 0.140 |
Why?
|
GTP-Binding Proteins | 2 | 2012 | 970 | 0.140 |
Why?
|
Documentation | 3 | 2015 | 865 | 0.140 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3444 | 0.140 |
Why?
|
Chromosomes, Human, Pair 3 | 3 | 2013 | 323 | 0.140 |
Why?
|
Integrin alpha Chains | 1 | 2016 | 97 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11472 | 0.140 |
Why?
|
Multigene Family | 3 | 2015 | 1102 | 0.140 |
Why?
|
rac GTP-Binding Proteins | 1 | 2016 | 163 | 0.140 |
Why?
|
Phenotype | 8 | 2016 | 16331 | 0.130 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2017 | 236 | 0.130 |
Why?
|
Casein Kinase II | 1 | 2016 | 128 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2011 | 987 | 0.130 |
Why?
|
Animals | 39 | 2018 | 168561 | 0.130 |
Why?
|
Nuclear Proteins | 5 | 2017 | 5851 | 0.130 |
Why?
|
Genes, Mitochondrial | 1 | 2015 | 61 | 0.130 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2017 | 337 | 0.130 |
Why?
|
Glioma | 3 | 2015 | 3388 | 0.130 |
Why?
|
Intestines | 2 | 2014 | 1923 | 0.130 |
Why?
|
Exonucleases | 1 | 2014 | 47 | 0.120 |
Why?
|
Mice | 25 | 2018 | 81045 | 0.120 |
Why?
|
Amino Acids | 3 | 2014 | 1727 | 0.120 |
Why?
|
Electron Transport | 1 | 2015 | 211 | 0.120 |
Why?
|
Molecular Sequence Annotation | 2 | 2014 | 527 | 0.120 |
Why?
|
Fibrosarcoma | 1 | 2016 | 348 | 0.120 |
Why?
|
Calcium Channels, L-Type | 1 | 2015 | 238 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 1860 | 0.120 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2007 | 436 | 0.110 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.110 |
Why?
|
Ecology | 1 | 2013 | 105 | 0.110 |
Why?
|
Epigenesis, Genetic | 4 | 2013 | 3639 | 0.110 |
Why?
|
Transcription Factors | 6 | 2017 | 12164 | 0.110 |
Why?
|
Polymorphism, Genetic | 3 | 2014 | 4328 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1118 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2016 | 939 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2016 | 325 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2915 | 0.110 |
Why?
|
Bile Acids and Salts | 1 | 2014 | 353 | 0.110 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 914 | 0.110 |
Why?
|
RNA, Untranslated | 1 | 2016 | 454 | 0.110 |
Why?
|
Neuronal Plasticity | 2 | 2012 | 1418 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2013 | 403 | 0.100 |
Why?
|
Quality Control | 1 | 2014 | 841 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1606 | 0.100 |
Why?
|
Gene Deletion | 4 | 2014 | 2751 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2010 | 1581 | 0.100 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 567 | 0.100 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 516 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2017 | 870 | 0.100 |
Why?
|
RNA-Binding Protein FUS | 1 | 2011 | 72 | 0.100 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 484 | 0.100 |
Why?
|
Genome, Bacterial | 2 | 2014 | 754 | 0.100 |
Why?
|
Rhodopsin | 1 | 2011 | 203 | 0.100 |
Why?
|
Trypsin | 1 | 2011 | 509 | 0.100 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2011 | 104 | 0.100 |
Why?
|
Nervous System Neoplasms | 1 | 2011 | 91 | 0.100 |
Why?
|
RNA-Binding Proteins | 4 | 2016 | 1899 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2013 | 1213 | 0.100 |
Why?
|
Protein Folding | 1 | 2014 | 843 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 731 | 0.090 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2013 | 252 | 0.090 |
Why?
|
Probability | 2 | 2013 | 2502 | 0.090 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 196 | 0.090 |
Why?
|
Promoter Regions, Genetic | 5 | 2017 | 5867 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6534 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 578 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2015 | 5163 | 0.090 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2011 | 249 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2014 | 435 | 0.090 |
Why?
|
Sequence Analysis, DNA | 4 | 2015 | 4801 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2013 | 2229 | 0.090 |
Why?
|
DNA Replication | 2 | 2014 | 1397 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 63 | 0.090 |
Why?
|
Female | 35 | 2018 | 379592 | 0.090 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 379 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3920 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2011 | 3617 | 0.090 |
Why?
|
Artificial Intelligence | 2 | 2015 | 2187 | 0.090 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 24 | 0.090 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2011 | 337 | 0.090 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 199 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 2 | 2011 | 1097 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2015 | 1101 | 0.090 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2007 | 1086 | 0.090 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 297 | 0.090 |
Why?
|
GTPase-Activating Proteins | 2 | 2010 | 497 | 0.090 |
Why?
|
Catalytic Domain | 1 | 2011 | 699 | 0.090 |
Why?
|
Drug Synergism | 1 | 2013 | 1791 | 0.090 |
Why?
|
Isoenzymes | 1 | 2014 | 1725 | 0.080 |
Why?
|
Skin Neoplasms | 5 | 2009 | 5662 | 0.080 |
Why?
|
PDZ Domains | 1 | 2008 | 22 | 0.080 |
Why?
|
RNA Interference | 2 | 2010 | 2890 | 0.080 |
Why?
|
Polyomavirus | 1 | 2009 | 248 | 0.080 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 670 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2011 | 596 | 0.080 |
Why?
|
Lysine | 1 | 2013 | 1008 | 0.080 |
Why?
|
RNA Stability | 1 | 2010 | 322 | 0.080 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1254 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2016 | 11363 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2016 | 2028 | 0.080 |
Why?
|
Biomedical Research | 3 | 2008 | 3306 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2014 | 5522 | 0.080 |
Why?
|
Fluorine Radioisotopes | 1 | 2011 | 448 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3585 | 0.080 |
Why?
|
Male | 35 | 2018 | 349538 | 0.080 |
Why?
|
Insulinoma | 1 | 2008 | 124 | 0.080 |
Why?
|
Cell Proliferation | 7 | 2014 | 10472 | 0.080 |
Why?
|
Polyomavirus Infections | 1 | 2009 | 196 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1780 | 0.080 |
Why?
|
Cell Line | 9 | 2015 | 15994 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2014 | 2837 | 0.070 |
Why?
|
Genetics, Medical | 1 | 2010 | 337 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 264 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2008 | 512 | 0.070 |
Why?
|
Glycolysis | 1 | 2011 | 825 | 0.070 |
Why?
|
Endoribonucleases | 1 | 2008 | 228 | 0.070 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 514 | 0.070 |
Why?
|
Polyadenylation | 2 | 2004 | 116 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1379 | 0.070 |
Why?
|
Tumor Virus Infections | 1 | 2009 | 451 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1221 | 0.070 |
Why?
|
Disease-Free Survival | 5 | 2015 | 6891 | 0.070 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 2 | 2018 | 170 | 0.070 |
Why?
|
Software Design | 1 | 2006 | 176 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2009 | 479 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2011 | 838 | 0.070 |
Why?
|
Gene Rearrangement | 1 | 2011 | 1179 | 0.070 |
Why?
|
Drug Design | 1 | 2011 | 1078 | 0.070 |
Why?
|
Pleural Neoplasms | 1 | 2011 | 607 | 0.070 |
Why?
|
Structural Homology, Protein | 2 | 2018 | 91 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 647 | 0.070 |
Why?
|
Middle Aged | 19 | 2018 | 213127 | 0.070 |
Why?
|
DEAD-box RNA Helicases | 1 | 2008 | 375 | 0.070 |
Why?
|
Prognosis | 7 | 2016 | 29010 | 0.070 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2009 | 299 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2011 | 2013 | 0.070 |
Why?
|
Adenocarcinoma | 3 | 2013 | 6347 | 0.070 |
Why?
|
Chromosome Aberrations | 2 | 2011 | 1811 | 0.070 |
Why?
|
Aged | 18 | 2018 | 162944 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2867 | 0.070 |
Why?
|
Hematopoietic System | 1 | 2005 | 108 | 0.070 |
Why?
|
Drosophila melanogaster | 2 | 2005 | 1704 | 0.060 |
Why?
|
Neoplasm Metastasis | 5 | 2014 | 4839 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1562 | 0.060 |
Why?
|
Cationic Amino Acid Transporter 1 | 1 | 2004 | 5 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3548 | 0.060 |
Why?
|
Disease | 1 | 2010 | 681 | 0.060 |
Why?
|
Androgens | 1 | 2012 | 1271 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3760 | 0.060 |
Why?
|
3' Untranslated Regions | 4 | 2012 | 508 | 0.060 |
Why?
|
Mesothelioma | 1 | 2011 | 818 | 0.060 |
Why?
|
Quantitative Trait Loci | 3 | 2018 | 2015 | 0.060 |
Why?
|
RNA | 3 | 2019 | 2747 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1782 | 0.060 |
Why?
|
Isotope Labeling | 2 | 2018 | 414 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2014 | 2714 | 0.060 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2417 | 0.060 |
Why?
|
Herpesviridae | 1 | 2005 | 109 | 0.060 |
Why?
|
Gene Library | 1 | 2007 | 1076 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 2986 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3564 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2623 | 0.060 |
Why?
|
Transfection | 2 | 2010 | 5892 | 0.060 |
Why?
|
Prostate | 2 | 2011 | 1764 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2658 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 1294 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2007 | 435 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2011 | 971 | 0.060 |
Why?
|
Cell Division | 1 | 2011 | 4564 | 0.060 |
Why?
|
Synapses | 2 | 2012 | 1724 | 0.060 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4465 | 0.060 |
Why?
|
Electroencephalography | 3 | 2018 | 6142 | 0.060 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2007 | 638 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2004 | 203 | 0.060 |
Why?
|
Recurrence | 2 | 2014 | 8333 | 0.060 |
Why?
|
Neoplasms, Experimental | 3 | 2014 | 1274 | 0.060 |
Why?
|
International Cooperation | 1 | 2010 | 1421 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3038 | 0.060 |
Why?
|
Adult | 17 | 2018 | 213712 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2013 | 19862 | 0.060 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2004 | 67 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2009 | 930 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2013 | 6754 | 0.060 |
Why?
|
Immunotherapy | 2 | 2016 | 4414 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2016 | 5019 | 0.050 |
Why?
|
Testis | 1 | 2006 | 800 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2274 | 0.050 |
Why?
|
Neoplasm Staging | 5 | 2016 | 11001 | 0.050 |
Why?
|
Angiofibroma | 1 | 2003 | 68 | 0.050 |
Why?
|
Genes, Fungal | 1 | 2004 | 455 | 0.050 |
Why?
|
Codon, Nonsense | 2 | 2014 | 281 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 2014 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4029 | 0.050 |
Why?
|
Memory | 1 | 2012 | 2163 | 0.050 |
Why?
|
Membrane Proteins | 4 | 2014 | 7873 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2011 | 2968 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1100 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2217 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 2 | 2004 | 587 | 0.050 |
Why?
|
Apoptosis | 7 | 2011 | 9715 | 0.050 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2008 | 849 | 0.050 |
Why?
|
Cell Differentiation | 4 | 2011 | 11470 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4751 | 0.050 |
Why?
|
Aplysia | 2 | 2012 | 41 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2003 | 245 | 0.050 |
Why?
|
Genome, Viral | 1 | 2005 | 667 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2374 | 0.050 |
Why?
|
Body Patterning | 1 | 2005 | 626 | 0.050 |
Why?
|
Embryonic Development | 1 | 2005 | 704 | 0.050 |
Why?
|
Lung Neoplasms | 3 | 2015 | 13019 | 0.050 |
Why?
|
Access to Information | 2 | 2016 | 320 | 0.050 |
Why?
|
Telomerase | 2 | 2016 | 729 | 0.050 |
Why?
|
Microsatellite Instability | 2 | 2014 | 678 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2008 | 1071 | 0.040 |
Why?
|
Prostatic Intraepithelial Neoplasia | 2 | 2011 | 76 | 0.040 |
Why?
|
Cell Cycle | 1 | 2008 | 2964 | 0.040 |
Why?
|
Protein Transport | 1 | 2006 | 1988 | 0.040 |
Why?
|
Hepacivirus | 1 | 2007 | 1372 | 0.040 |
Why?
|
Repressor Proteins | 3 | 2011 | 3020 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2008 | 3199 | 0.040 |
Why?
|
Cloning, Molecular | 4 | 2007 | 4322 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2005 | 4742 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2008 | 2440 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2013 | 890 | 0.040 |
Why?
|
Virus Replication | 1 | 2007 | 2531 | 0.040 |
Why?
|
Deuterium | 1 | 2018 | 101 | 0.040 |
Why?
|
Natural Language Processing | 2 | 2004 | 1035 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2004 | 1040 | 0.040 |
Why?
|
Brain | 3 | 2018 | 26343 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1895 | 0.040 |
Why?
|
Ligands | 1 | 2006 | 3293 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2010 | 496 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1624 | 0.040 |
Why?
|
Polymerase Chain Reaction | 4 | 2010 | 6171 | 0.040 |
Why?
|
Data Mining | 2 | 2014 | 537 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2014 | 9735 | 0.040 |
Why?
|
Rats | 4 | 2007 | 24265 | 0.040 |
Why?
|
Bipolar Disorder | 1 | 2015 | 5024 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2011 | 6259 | 0.040 |
Why?
|
Transplantation, Heterologous | 3 | 2012 | 2382 | 0.040 |
Why?
|
Kinetics | 1 | 2006 | 6474 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2011 | 3748 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2009 | 2542 | 0.040 |
Why?
|
Soft Tissue Neoplasms | 1 | 2007 | 1361 | 0.040 |
Why?
|
Thermodynamics | 1 | 2018 | 594 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2906 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2015 | 1683 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2018 | 57683 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 4030 | 0.030 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2016 | 33 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5171 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2018 | 474 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12344 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2018 | 6365 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5249 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 12695 | 0.030 |
Why?
|
DNA | 1 | 2010 | 7289 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2015 | 1538 | 0.030 |
Why?
|
Disease Progression | 4 | 2018 | 13256 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 1596 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 135 | 0.030 |
Why?
|
Directed Molecular Evolution | 1 | 2016 | 161 | 0.030 |
Why?
|
RNA, Viral | 1 | 2004 | 2899 | 0.030 |
Why?
|
Neurons | 2 | 2012 | 9325 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4379 | 0.030 |
Why?
|
Medical Oncology | 1 | 2007 | 2235 | 0.030 |
Why?
|
Skin | 1 | 2008 | 4353 | 0.030 |
Why?
|
Receptors, Androgen | 2 | 2012 | 1057 | 0.030 |
Why?
|
Gene Knockdown Techniques | 2 | 2010 | 1655 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1792 | 0.030 |
Why?
|
Tuberous Sclerosis | 1 | 2003 | 1029 | 0.030 |
Why?
|
Chromatin | 2 | 2017 | 2917 | 0.030 |
Why?
|
Replication Origin | 1 | 2014 | 77 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 65 | 0.030 |
Why?
|
Organ Specificity | 2 | 2013 | 2003 | 0.030 |
Why?
|
Genotype | 4 | 2014 | 12946 | 0.030 |
Why?
|
Clostridium | 1 | 2014 | 98 | 0.030 |
Why?
|
Endometrial Neoplasms | 2 | 2014 | 1351 | 0.030 |
Why?
|
DNA Polymerase III | 1 | 2014 | 55 | 0.030 |
Why?
|
Hydrodynamics | 1 | 2015 | 158 | 0.030 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 74 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2004 | 1884 | 0.030 |
Why?
|
Germany | 2 | 2009 | 860 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 366 | 0.030 |
Why?
|
HeLa Cells | 2 | 2010 | 3127 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2015 | 563 | 0.030 |
Why?
|
Up-Regulation | 2 | 2016 | 4211 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 721 | 0.030 |
Why?
|
Succinate Dehydrogenase | 1 | 2014 | 146 | 0.030 |
Why?
|
E2F3 Transcription Factor | 1 | 2013 | 40 | 0.030 |
Why?
|
Research Design | 2 | 2007 | 5979 | 0.030 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2013 | 58 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2015 | 281 | 0.030 |
Why?
|
Zebrafish | 1 | 2005 | 2990 | 0.030 |
Why?
|
Liver | 3 | 2017 | 7470 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 314 | 0.030 |
Why?
|
Organisms, Genetically Modified | 1 | 2013 | 64 | 0.030 |
Why?
|
Medical Records | 2 | 2013 | 1413 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2018 | 790 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 157 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2723 | 0.030 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 2012 | 34 | 0.030 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 1 | 2012 | 30 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2013 | 162 | 0.030 |
Why?
|
Taxoids | 1 | 2016 | 665 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 657 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2749 | 0.030 |
Why?
|
Ribosomes | 1 | 2016 | 499 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2011 | 6313 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5180 | 0.030 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2012 | 62 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2016 | 581 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2011 | 3612 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2085 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2012 | 115 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2016 | 4438 | 0.030 |
Why?
|
Cell Physiological Phenomena | 1 | 2013 | 154 | 0.030 |
Why?
|
Symbiosis | 1 | 2014 | 283 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2013 | 188 | 0.030 |
Why?
|
Gene Frequency | 2 | 2013 | 3587 | 0.030 |
Why?
|
RNA Splicing | 1 | 2016 | 907 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4553 | 0.020 |
Why?
|
New York City | 1 | 2013 | 706 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 553 | 0.020 |
Why?
|
Neurofibromin 2 | 1 | 2012 | 267 | 0.020 |
Why?
|
Metagenome | 1 | 2014 | 417 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7721 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12705 | 0.020 |
Why?
|
COS Cells | 1 | 2013 | 1160 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 137 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 704 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 732 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 364 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.020 |
Why?
|
E2F Transcription Factors | 1 | 2011 | 274 | 0.020 |
Why?
|
Genes | 1 | 2015 | 1892 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 906 | 0.020 |
Why?
|
Survival Rate | 2 | 2016 | 12773 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2017 | 9639 | 0.020 |
Why?
|
Phylogeny | 2 | 2008 | 2797 | 0.020 |
Why?
|
Intellectual Property | 1 | 2010 | 31 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2011 | 286 | 0.020 |
Why?
|
RNA-Binding Protein EWS | 1 | 2011 | 216 | 0.020 |
Why?
|
Computers | 1 | 2013 | 611 | 0.020 |
Why?
|
Orchiectomy | 1 | 2012 | 466 | 0.020 |
Why?
|
Phosphorylation | 2 | 2013 | 8436 | 0.020 |
Why?
|
Cytokinesis | 1 | 2011 | 177 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2012 | 627 | 0.020 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2012 | 414 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 400 | 0.020 |
Why?
|
Half-Life | 1 | 2010 | 658 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 322 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2012 | 625 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2003 | 3843 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2013 | 1341 | 0.020 |
Why?
|
Genomic Instability | 1 | 2013 | 695 | 0.020 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2009 | 55 | 0.020 |
Why?
|
Biochemistry | 1 | 2010 | 113 | 0.020 |
Why?
|
Genes, cdc | 1 | 2009 | 116 | 0.020 |
Why?
|
Viral Proteins | 2 | 2008 | 1899 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1640 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2013 | 19223 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2790 | 0.020 |
Why?
|
Glucose | 2 | 2011 | 4391 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2011 | 905 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1074 | 0.020 |
Why?
|
Feces | 1 | 2014 | 1394 | 0.020 |
Why?
|
Adipogenesis | 1 | 2011 | 358 | 0.020 |
Why?
|
Skin Abnormalities | 1 | 2008 | 60 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2009 | 2906 | 0.020 |
Why?
|
Databases as Topic | 1 | 2010 | 475 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 21821 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 768 | 0.020 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2009 | 377 | 0.020 |
Why?
|
Antigens, Viral, Tumor | 1 | 2008 | 154 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1526 | 0.020 |
Why?
|
Integrin alphaVbeta3 | 1 | 2008 | 111 | 0.020 |
Why?
|
Pyrroles | 1 | 2014 | 1143 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 2008 | 449 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1525 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2895 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2009 | 433 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1434 | 0.020 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2007 | 67 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1157 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5519 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 2170 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 964 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2008 | 275 | 0.020 |
Why?
|
Cell Movement | 2 | 2010 | 5212 | 0.020 |
Why?
|
Cell Survival | 2 | 2008 | 5872 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2011 | 971 | 0.020 |
Why?
|
Colitis | 1 | 2014 | 1149 | 0.020 |
Why?
|
Astrocytoma | 1 | 2011 | 789 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 625 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1119 | 0.020 |
Why?
|
Viral Nonstructural Proteins | 1 | 2007 | 241 | 0.020 |
Why?
|
Molecular Biology | 1 | 2009 | 595 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1834 | 0.020 |
Why?
|
Education | 1 | 2008 | 543 | 0.020 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 57 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2006 | 262 | 0.020 |
Why?
|
Ubiquitination | 1 | 2009 | 1011 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2009 | 874 | 0.020 |
Why?
|
Serotonin | 1 | 2009 | 1024 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4024 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3701 | 0.020 |
Why?
|
Untranslated Regions | 1 | 2004 | 31 | 0.020 |
Why?
|
Mice, SCID | 1 | 2009 | 2715 | 0.020 |
Why?
|
Ecdysone | 1 | 2003 | 17 | 0.020 |
Why?
|
Immune System | 1 | 2010 | 804 | 0.020 |
Why?
|
Callithrix | 1 | 2004 | 93 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2572 | 0.010 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2004 | 117 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2002 | 9185 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 40450 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1581 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2007 | 880 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2008 | 14554 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2885 | 0.010 |
Why?
|
Th1 Cells | 1 | 2008 | 1056 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3689 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6931 | 0.010 |
Why?
|
Genes, Insect | 1 | 2003 | 268 | 0.010 |
Why?
|
Breast | 1 | 2012 | 1958 | 0.010 |
Why?
|
DNA, Viral | 1 | 2009 | 2224 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2010 | 1887 | 0.010 |
Why?
|
Genes, Essential | 1 | 2004 | 182 | 0.010 |
Why?
|
RNA, Double-Stranded | 1 | 2004 | 289 | 0.010 |
Why?
|
Genes, Homeobox | 1 | 2003 | 286 | 0.010 |
Why?
|
Overweight | 1 | 2013 | 2366 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4200 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39004 | 0.010 |
Why?
|
Child, Preschool | 3 | 2015 | 40955 | 0.010 |
Why?
|
Central Nervous System | 1 | 2009 | 1354 | 0.010 |
Why?
|
Time Factors | 3 | 2009 | 40054 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 936 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3339 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 2005 | 894 | 0.010 |
Why?
|
Introns | 1 | 2004 | 991 | 0.010 |
Why?
|
Virus Latency | 1 | 2004 | 356 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7167 | 0.010 |
Why?
|
History, 20th Century | 1 | 2009 | 2739 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4249 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9846 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2004 | 2049 | 0.010 |
Why?
|
Imidazoles | 1 | 2007 | 1205 | 0.010 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2011 | 1421 | 0.010 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2004 | 484 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2638 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2006 | 2723 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6452 | 0.010 |
Why?
|
Retinitis Pigmentosa | 1 | 2004 | 386 | 0.010 |
Why?
|
Adipocytes | 1 | 2007 | 1182 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2018 | 4628 | 0.010 |
Why?
|
Nevus | 1 | 2002 | 204 | 0.010 |
Why?
|
Nervous System | 1 | 2003 | 553 | 0.010 |
Why?
|
Reference Standards | 1 | 2004 | 1020 | 0.010 |
Why?
|
Neuropeptides | 1 | 2005 | 942 | 0.010 |
Why?
|
Young Adult | 2 | 2016 | 56350 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2004 | 1121 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13403 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3800 | 0.010 |
Why?
|
Cell Lineage | 1 | 2007 | 2504 | 0.010 |
Why?
|
Research | 1 | 2007 | 1999 | 0.010 |
Why?
|
Internationality | 1 | 2004 | 1002 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14720 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 8969 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3328 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2633 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18355 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7901 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2018 | 7988 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2004 | 1402 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.010 |
Why?
|
Adolescent | 3 | 2015 | 85649 | 0.010 |
Why?
|
Child | 3 | 2015 | 77478 | 0.010 |
Why?
|
Piperazines | 1 | 2007 | 2488 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2004 | 1190 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2003 | 1548 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7153 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4392 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2005 | 1699 | 0.010 |
Why?
|
Parkinson Disease | 1 | 2009 | 2774 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1820 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21719 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2007 | 3278 | 0.010 |
Why?
|
Brain Mapping | 1 | 2011 | 6669 | 0.010 |
Why?
|
Cystic Fibrosis | 1 | 2004 | 1178 | 0.010 |
Why?
|
Risk Factors | 2 | 2013 | 72145 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 3381 | 0.010 |
Why?
|
United States | 2 | 2015 | 69693 | 0.010 |
Why?
|
Blood Glucose | 1 | 2008 | 6249 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18006 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2013 | 77098 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8621 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12958 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15056 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2002 | 15530 | 0.000 |
Why?
|